Bharat Rakshak

SinghS wrote:Sir, daak sent.

SinghS wrote:Sir, daak sent.

A World Health Organization technical advisory group was reviewing data on India's Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said.
"If all is in place and all goes well and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so," Margaret Harris told journalists at a U.N. press briefing

Ashokk wrote:Review of India's Covaxin shot underway, WHO says

A World Health Organization technical advisory group was reviewing data on India's Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said.
"If all is in place and all goes well and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so," Margaret Harris told journalists at a U.N. press briefing

Deans wrote:

Amber G. wrote:Good News: IIT Hyderabad will carry on the outstanding work of covid19india. A beta version of the website is at:
https://covid19tracker.in
(Thanks to some members of Sutra team for making this happen)

Of interest to BRF will be the role of Lt. Gen. Madhuri Kanitkar, in SUTRA. She's the senior most lady officer in the forces. A very charismatic and
intellectually brilliant person.

Amber G. wrote:^^^(Bharat Biotech applied for EUA in April and Covaxin having been administered to 117 million Indians as of today...
WHO's Advisory Group met yesterday to consider EUA approval and again asked for "additional clarifications." Six months of playing this game continues till the next meeting on Nov. 3rd.

Uttam wrote:
A few months ago, a number of editorial articles kept defending the high Covid infection rates in Kerala based on the low death rates.

Over the last two months, the infection level have come down very significantly but the death rates have shot up. This to me is a clear evidence of Kerala govt. hiding the actual number of death. Now they are quietly moving people from active to death categories. Shameful

Amber G. wrote: It may take scientists some time to study but it is not helpful to blame other states motives - their method may be criticized but there is NO clear evidence of significant hiding of data.

A report released Tuesday by Public Citizen, a consumer rights advocacy group that gained access to a number of leaked, unredacted Pfizer contracts, sheds light on how the company uses that power to “shift risk and maximize profits,” the organization argues.


The Manhattan-based pharmaceutical giant has maintained tight levels of secrecy about negotiations with governments over contracts that can determine the fate of populations. The “contracts consistently place Pfizer’s interests before public health imperatives,” said Zain Rizvi, the researcher who wrote the report.

Public Citizen found common themes across contracts, including not only secrecy but also language to block donations of Pfizer doses. Disputes are settled in secret arbitration courts, with Pfizer able to change the terms of key decisions, including delivery dates, and demand public assets as collateral.

It will help vaccinate the world’s low-income countries in the coming months to fill the 9 billion gap, Hotez said.

“The Covid-19 vaccine, which will be released for emergency use in India soon, will produce 100 million doses per month. It has been tough, but the most fulfilling activity I've ever been involved with,” he said.

The World Health Organisation (WHO) respects the Biological E, he said.

“It mentioned, once a vaccine is released in India, we will most likely move pretty close to do emergency assistance for global usage, so the world can benefit from it as well,” Hotez said.

“Our shared goal is to make this vaccine available not only for India, but all of the world’s low- and middle-income countries as a means to end the pandemic,” Hotez said during his keynote address.

Hotez said that this adventure would never have happened without the brilliance of Indian scientists and various Texas philanthropists, including Texas Children Hospital and M D Anderson Foundation, who raised USD 7 million for vaccine development.

Appreciating Indian vaccine producers amidst thunderous applause from over 600 attendees at the 22nd IACCGH gala, Hotez said, “India’s vaccine producers are actually “India’s gift to the world”.

NEW DELHI: The World Health Organization (WHO) gave emergency use approval for Bharat Biotech's Covaxin vaccine on Wednesday, reported PTI citing sources.
The approval by the Technical Advisory Group (TAG), an independent advisory panel of the WHO, was expected on October 26, but the WHO had deferred its decision and sought additional clarifications from Bharat Biotech to conduct a final risk-benefit assessment.
Earlier in the day, the Central Drugs Standard Control Organisation approved extension of shelf life of Covaxin up to 12 months, from date of manufacture. This approval is based on the availability of additional stability data, which was submitted to CDSCO.
Covaxin has demonstrated 77.8% effectiveness against symptomatic Covid-19 and 65.2% protection against the new Delta variant. In June, the company had said it concluded the final analysis of Covaxin efficacy from Phase 3 trials.
Covaxin and AstraZeneca's Covishield are the two widely used vaccines in India.
The WHO has already approved six vaccines for emergency use: AstraZeneca's Covishield, Moderna's mRNA-1273, Sinopharm's BBIBP-CorV, Sinovac's CoronaVac, Pfizer/BioNTech's Comirnaty, and Johnson & Johnson's vaccine.
Last week, the WHO had said the timeframe for it Emergency Use Listing procedure is dependant on how quickly a manufacturing company producing the vaccine is able to provide data required for the WHO to evaluate the vaccine's efficacy, safety, quality, and its suitability for low and middle-income countries.
Many countries have already approved Covaxin to ease international travel, including Guyana, Iran, Mauritius, Mexico, Nepal, Paraguay, Philippines, Zimbabwe, and Australia.

vijayk wrote:https://twitter.com/danielocarmon/statu ... 2409374733
Daniel CarmonFlag of Israel @danielocarmon Happening now at #COP26 in #Glasgow @narendramodi
,
@naftalibennett credit @WallaNews @BarakRavid


Check the video there .. Modiji and Israeli PM. Shows great connection.
But also really getting concerned that Modiji is not using a mask. I hope he does not get infected.

Lisa wrote:'WHO approves Bharat Biotech's Covaxin for emergency use'

https://timesofindia.indiatimes.com/ind ... 497013.cms

Manish_P wrote:^ with an expected snarky note that it believed the benefits far outweighed the risks.

Doesn't matter. The poodle of China can whimper all it wants..

By the end of September, Moderna’s two-dose COVID-19 vaccine, measured as 89% effective in March, was only 58% effective.

The effectiveness of shots made by Pfizer and BioNTech vaccine, which also employed two doses, fell from 87% to 45% in the same period.

And most strikingly, the protective power of Johnson & Johnson’s single-dose vaccine plunged from 86% to just 13% over those six months.

vera_k wrote:Explains why the virus is not dying out, since the vaccines are not able to prevent asymptomatic transmission.

Study shows dramatic decline in effectiveness of all three COVID-19 vaccines over time

By the end of September, Moderna’s two-dose COVID-19 vaccine, measured as 89% effective in March, was only 58% effective.

The effectiveness of shots made by Pfizer and BioNTech vaccine, which also employed two doses, fell from 87% to 45% in the same period.

And most strikingly, the protective power of Johnson & Johnson’s single-dose vaccine plunged from 86% to just 13% over those six months.

rajkumar wrote:

vera_k wrote:Explains why the virus is not dying out, since the vaccines are not able to prevent asymptomatic transmission.

Study shows dramatic decline in effectiveness of all three COVID-19 vaccines over time

The world is going to be in a permanent 6 month booster dose scenario for the for see able future. The pharma industry is incredibly happy since this is revenue stream that none of them had forecast in their 5 year plans.

But are vaccines are still holding up against death and serious illness?
The Delta variant’s mutations — combined with waning vaccine antibodies — are causing more breakthrough infections. But vaccines are still offering remarkable protection against hospitalization and death. A study at the University of Edinburgh, UK, found that the Pfizer–BioNTech and Oxford–AstraZeneca vaccines were 90% and 91% effective, respectively, at preventing death. Furthermore, around 75,000 people required hospital treatment for COVID-19 in the United Kingdom between the start of July and early October this year, compared with 185,000 between October 2020 and January 2021, when the number of infections was comparable but vaccines were less available.

Relative to the size of its population, the United Kingdom has around three times as many infections as the United States, but only two-thirds the daily deaths. “The amount of infection that is currently going on in the UK would be expected to have much worse consequences if replicated elsewhere,” says Hanage.